Kevin Finney insider trades
Open-market stock purchases and sales by Kevin Finney, Director at Vaxart, Inc, from SEC Form 4 filings since Jan 28, 2025.
Track record: 100% of 5 scored buys are up 5% or more since purchase, averaging +56%.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- VXRT Vaxart, Inc: 5 buys, last Aug 15, 2025